KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Operating Margin (2016 - 2026)

Evolent Health has reported Operating Margin over the past 11 years, most recently at 87.1% for Q4 2025.

  • For Q4 2025, Operating Margin fell 8422.0% year-over-year to 87.1%; the TTM value through Dec 2025 reached 21.86%, down 2027.0%, while the annual FY2025 figure was 21.86%, 2027.0% down from the prior year.
  • Operating Margin for Q4 2025 was 87.1% at Evolent Health, down from 0.18% in the prior quarter.
  • Over five years, Operating Margin peaked at 3.67% in Q3 2022 and troughed at 87.1% in Q4 2025.
  • A 5-year average of 6.31% and a median of 2.52% in 2023 define the central range for Operating Margin.
  • Biggest five-year swings in Operating Margin: surged 10047bps in 2021 and later crashed -8422bps in 2025.
  • Year by year, Operating Margin stood at 4.92% in 2021, then skyrocketed by 90bps to 0.49% in 2022, then tumbled by -682bps to 3.84% in 2023, then rose by 25bps to 2.88% in 2024, then plummeted by -2928bps to 87.1% in 2025.
  • Business Quant data shows Operating Margin for EVH at 87.1% in Q4 2025, 0.18% in Q3 2025, and 0.26% in Q2 2025.